Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,531 | 42,049 | 64,493 | 84,823 | 109,587 |
| Receivables | 6,190 | 15,976 | 6,174 | 10,569 | 4,935 |
| Other current assets | 4,825 | 5,707 | 5,136 | 4,806 | 3,125 |
| TOTAL | $40,546 | $63,732 | $75,803 | $100,198 | $117,647 |
| Non-Current Assets | |||||
| PPE Net | 14,673 | 11,688 | 9,254 | 7,008 | 6,062 |
| Intangibles | 24,394 | 24,670 | 24,946 | 25,222 | 25,498 |
| Other Non-Current Assets | 18,731 | 19,380 | 20,049 | 20,353 | 14,997 |
| TOTAL | $57,798 | $55,738 | $54,249 | $52,583 | $46,557 |
| Total Assets | $98,344 | $119,470 | $130,052 | $152,781 | $164,204 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,240 | 7,117 | 6,437 | 5,806 | 6,064 |
| Accounts payable and accrued liabilities | 2,860 | 1,249 | 674 | 272 | 564 |
| Accrued Expenses | 8,383 | 13,103 | 12,461 | 16,938 | 9,504 |
| Other current liabilities | N/A | N/A | N/A | N/A | 7,900 |
| TOTAL | $19,099 | $22,068 | $20,144 | $23,571 | $24,446 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,166 | 31,910 | 34,489 | 36,342 | 37,568 |
| Other Non-Current Liabilities | 18,432 | 18,905 | 19,454 | 20,112 | 18,787 |
| TOTAL | $48,632 | $50,849 | $53,971 | $56,482 | $56,383 |
| Total Liabilities | $67,731 | $72,917 | $74,115 | $80,053 | $80,829 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,597 | 86,597 | 86,422 | 86,422 | 84,543 |
| Common Shares | 113 | 113 | 112 | 112 | 110 |
| Retained earnings | -694,561 | -677,760 | -666,485 | -647,643 | -627,943 |
| Other shareholders' equity | -68 | 111 | -46 | -768 | 112 |
| TOTAL | $30,613 | $46,553 | $55,937 | $72,728 | $83,375 |
| Total Liabilities And Equity | $98,344 | $119,470 | $130,052 | $152,781 | $164,204 |